Case Summary:

At North America Immigration Law Group, we are thrilled to announce the successful approval of an I-140 National Interest Waiver (NIW) petition for an accomplished PhD holder in neurobiology. The petition was approved after 15 months and 19 days without receiving any RFEs.

The petitioner is an expert in neuroscience whose research holds substantial merit and national importance by striving to decrease the mortality of neurodegenerative disorders and reduce national healthcare expenditure. Neurological disorders currently cause approximately 9 million deaths annually worldwide and impose a significant economic burden on the U.S. healthcare system, estimated at nearly $800 billion annually. By identifying specific neuronal dynamics and molecular mechanisms, the researcher’s work reveals new therapeutic targets for debilitating conditions such as Alzheimer’s and Parkinson’s disease, thereby ensuring the U.S. healthcare system has effective tools to combat this growing crisis.

The client is currently employed as a staff scientist at a U.S. institution, where they intend to continue their research into the cellular and molecular mechanisms of learning and memory and to publish original neuroscience research in peer-reviewed journals and conferences.

To support the NIW petition, we presented compelling evidence of the researcher’s distinguished contributions to the field of neuroscience:

● 16 peer-reviewed journal articles. These publications have appeared in highly ranked venues, demonstrating recognition of their value by peers.

● An impressive citation count of 403, indicating widespread recognition and reliance on their research by scholars globally.

● Additionally, the client serves as a review editor, having completed at least 3 reviews for authoritative journals, further underscoring their recognized expertise.

● The national importance of their research is further validated by funding received from prestigious organizations, including the National Institutes of Health (NIH), the National Natural Science Foundation of China (NSFC), the European Research Council, and China’s Ministry of Science and Technology.

The petition was further strengthened by 2 compelling letters of recommendation from distinguished experts in neuroscience, who attested to the scientist’s achievements and the national importance of their ongoing work. One recommender noted:

“[Client’s] pioneering research has revolutionized the understanding of neurobiology, particularly in Alzheimer’s disease. His groundbreaking work on amyloid beta’s neurotoxic effects, the evaluation of melatonin as a therapeutic agent, and his contributions to cerebellar research have solidified his position at the forefront of neuroscientific advancements.”

We are honored to have supported this gifted expert and look forward to their continued groundbreaking contributions to understanding brain function and developing treatments for neurological disorders in the United States and globally.